Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC) released its financial results for the quarter ended September 30, 2022, revealing revenue of CA$3.4 million ($2.5 million), a 4% decrease compared to CA$3.6 million in the Q3 2021.